SCHEMBL8210944

SCHEMBL8210944

C=C(c1ccccc1)c1ccccc1.[KH]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
MAPT P10636 4/20 0.50
HSD17B10 Q99714 2/20 0.50
HTT P42858 1/20 0.50
GFER P55789 1/20 0.50
GPR55 Q9Y2T6 1/20 0.50
CES1 P23141 3/20 0.45
CES2 O00748 2/20 0.45
TSHR P16473 2/20 0.45
DAO P14920 1/20 0.45
NAPRT Q6XQN6 1/20 0.45
ALDH1A1 P00352 1/20 0.45
MAOA P21397 2/20 0.42
MAOB P27338 2/20 0.42
AKT1 P31749 1/20 0.42
CYP3A4 P08684 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
F2 P00734 1/20 0.41
F10 P00742 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL28340939 0.97 MEN1 (0.61) MEN1KMT2AMAPTHSD17B10HTT
SCHEMBL7930063 0.97 MEN1 (0.61) MEN1KMT2AMAPTHSD17B10HTT
SCHEMBL3844822 0.97 MEN1 (0.61) MEN1KMT2AMAPTHSD17B10HTT
SCHEMBL26736 0.97 MEN1 (0.61) MEN1KMT2AMAPTHSD17B10HTT
Benzene SCHEMBL9731493 0.97 MEN1 (0.61) MEN1KMT2AMAPTHSD17B10HTT
SCHEMBL11434494 0.93 MEN1 (0.58) MEN1KMT2AMAPTHSD17B10HTT
Ethylene SCHEMBL6524259 0.93 MEN1 (0.58) MEN1KMT2AMAPTHSD17B10HTT
SCHEMBL894135 0.93 MEN1 (0.65) MEN1KMT2AMAPTHSD17B10HTT
Hydrochloric Acid SCHEMBL10598447 0.93 KMT2A (0.58) MEN1KMT2AMAPTHSD17B10HTT
SCHEMBL9580054 0.93 MEN1 (0.58) MEN1KMT2AMAPTHSD17B10HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102510857-B method for producing 3-substituted-oxy-4-pyridazinol derivative MITSUI CHEMICALS AGRO INC 2015-05-13 CN claimed
US-8552182-B2 Method for producing a 3-(substituted-oxy)-4-pyridazinol derivative MITSUI CHEMICALS AGRO, INC. (JP) 2013-10-08 US claimed
US-20120184736-A1 METHOD FOR PRODUCING A 3-(SUBSTITUTED-OXY)-4-PYRIDAZINOL DERIVATIVE MITSUI CHEMICALS AGRO, INC (JP) 2012-07-19 US claimed
CN-102510857-A method for producing 3-substituted-oxy-4-pyridazinol derivative MITSUI CHEMICALS AGRO INC 2012-06-20 CN claimed
CN-102510857-B method for producing 3-substituted-oxy-4-pyridazinol derivative MITSUI CHEMICALS AGRO INC 2015-05-13 CN disclosed
US-8552182-B2 Method for producing a 3-(substituted-oxy)-4-pyridazinol derivative MITSUI CHEMICALS AGRO, INC. (JP) 2013-10-08 US disclosed
US-20120184736-A1 METHOD FOR PRODUCING A 3-(SUBSTITUTED-OXY)-4-PYRIDAZINOL DERIVATIVE MITSUI CHEMICALS AGRO, INC (JP) 2012-07-19 US disclosed
CN-102510857-A method for producing 3-substituted-oxy-4-pyridazinol derivative MITSUI CHEMICALS AGRO INC 2012-06-20 CN disclosed
US-6025437-A Block-graft copolymer, self-crosslinked polymer solid electrolyte and composite solid electrolyte manufactured through use of the block-graft copolymer, and solid cell employing the composite solid electrolyte SHIN-ETSU CHEMICAL CO., LTD. (JP) 2000-02-15 US disclosed
US-5219681-A Lithium cell SHIN-ETSU CHEMICAL CO., LTD. (JP) 1993-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184736-A1 METHOD FOR PRODUCING A 3-(SUBSTITUTED-OXY)-4-PYRIDAZINOL DERIVATIVE CYP4F3, CYP4F2, PNPO MEN1 4158/4885KMT2A 4298/4885MAPT 2790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.